Skip to content

Nasdaq · CIK 0001417663

SNWV SANUWAVE Health, Inc.

Insider trading from SEC Form 4. Last filing 10 d ago. Close $5.62 on Oct 9, 2026, +41% from the 52-week low and -84% from the high.

Last 90 days

Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
9
with a Form 4 at this company

Price and insider trades, last year

SNWVOct 9, 2026 · close 5.62

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

Open-market buys and sells at SANUWAVE Health, Inc., scored.

ScoreInsiderValueHoldingsPrice contextFiled
36WeakMorgan C. Frank
Chief Executive Officer
sell
$559k
20,000 shares
-24%+56% from low-30% from high
42ModerateMorgan C. Frank
Chief Executive Officer
sell
$4.5M
144,810 shares
-14%+54% from low-34% from high
42ModerateMorgan C. Frank
Chief Executive Officer
sell
$4.5M
144,810 shares
-14%+54% from low-34% from high
18WeakOpaleye Management Inc.
owner
buy
$38k
1,267 shares
+0%+213% from low-9% from high
22WeakPeter Stegagno
Chief Operating Officer
sell
$52k
1,862 shares
-48%+113% from low-28% from high
30WeakIulian Cioanta
Chief Sci. and Tech. Officer
sell
$115k
3,639 shares
-99%+140% from low-19% from high
32WeakOpaleye Management Inc.
owner
buy
$204k
7,998 shares
+1%+98% from low-33% from high
32WeakOpaleye Management Inc.
owner
buy
$439k
27,868 shares
+3%-
46ModerateMorgan C. Frank
Chief Executive Officer
buy
$1.5M
181,818 shares
+22%-

Transactions

The last 100 rows filed, every code.

DateInsiderTransactionSharesPriceValueHoldings afterFiled
Sep 30, 2026Morgan C. Frank
Chief Executive Officer
AGrant or award
Stock Option (right to buy)derivative
+11,286$0.00$011,28610 d ago
Sep 30, 2026Jeffrey Blizard
director
AGrant or award
Stock Option (right to buy)derivative
+11,286$0.00$011,28610 d ago
Sep 30, 2026Gregory Matthew Bazar
director
AGrant or award
Stock Option (right to buy)derivative
+11,286$0.00$011,28610 d ago
Sep 30, 2026James Tyler
director
AGrant or award
Stock Option (right to buy)derivative
+11,286$0.00$011,28610 d ago
Sep 30, 2026Ian D. Miller
director
AGrant or award
Stock Option (right to buy)derivative
+12,697$0.00$012,69710 d ago
Jan 30, 2026Morgan C. Frank
Chief Executive Officer
AGrant or award
Stock Option (right to buy)derivative
+24,000$0.00$024,000Feb 3, 2026
Dec 31, 2025Morgan C. Frank
Chief Executive Officer
AGrant or award
Stock Option (right to buy)derivative
+1,540$0.00$01,540Jan 6, 2026
Dec 31, 2025Jeffrey Blizard
director
AGrant or award
Stock Option (right to buy)derivative
+1,540$0.00$01,540Jan 6, 2026
Dec 31, 2025Gregory Matthew Bazar
director
AGrant or award
Stock Option (right to buy)derivative
+1,540$0.00$01,540Jan 6, 2026
Dec 11, 2025Morgan C. Frank
Chief Executive Officer
SOpen-market sale
Common Stock, par value $0.001indirect: See Footnote
-13,500$31.28$422k70,499Dec 15, 2025
Dec 12, 2025Morgan C. Frank
Chief Executive Officer
SOpen-market sale
Common Stock, par value $0.001indirect: See Footnote
-6,500$21.04$137k63,999Dec 15, 2025
Dec 8, 2025Morgan C. Frank
Chief Executive Officer
SOpen-market sale
Common Stock, par value $0.001indirect: See footnote
-125,400$30.75$3.9M881,390Dec 11, 2025
Dec 9, 2025Morgan C. Frank
Chief Executive Officer
SOpen-market sale
Common Stock, par value $0.001indirect: See footnote
-8,785$30.58$269k872,605Dec 11, 2025
Dec 10, 2025Morgan C. Frank
Chief Executive Officer
SOpen-market sale
Common Stock, par value $0.001indirect: See footnote
-8,625$30.39$262k863,980Dec 11, 2025
Dec 8, 2025Morgan C. Frank
Chief Executive Officer
SOpen-market sale
Common Stock, par value $0.001
-2,000$31.60$63k2,000Dec 11, 2025
Dec 8, 2025Morgan C. Frank
Chief Executive Officer
SOpen-market sale
Common Stock, par value $0.001indirect: See footnote
-125,400$30.75$3.9M881,390Dec 10, 2025
Dec 9, 2025Morgan C. Frank
Chief Executive Officer
SOpen-market sale
Common Stock, par value $0.001indirect: See footnote
-8,785$30.58$269k872,605Dec 10, 2025
Dec 10, 2025Morgan C. Frank
Chief Executive Officer
SOpen-market sale
Common Stock, par value $0.001indirect: See footnote
-8,625$30.39$262k863,980Dec 10, 2025
Dec 8, 2025Morgan C. Frank
Chief Executive Officer
SOpen-market sale
Common Stock, par value $0.001
-2,000$31.60$63k2,000Dec 10, 2025
Oct 6, 2025Opaleye Management Inc.
owner
POpen-market purchase
Common Stock, par value $0.001 per shareindirect: By Opaleye, L.P.
+1,267$30.28$38k966,267Oct 9, 2025
Sep 30, 2025Gregory Matthew Bazar
director
AGrant or award
Stock Option (right to buy)derivative
+1,342$0.00$01,342Oct 2, 2025
Sep 30, 2025Ian D. Miller
director
AGrant or award
Stock Option (right to buy)derivative
+1,510$0.00$01,510Oct 2, 2025
Sep 30, 2025Morgan C. Frank
Chief Executive Officer
AGrant or award
Stock Option (right to buy)derivative
+1,342$0.00$01,342Oct 2, 2025
Sep 30, 2025James Tyler
director
AGrant or award
Stock Option (right to buy)derivative
+1,342$0.00$01,342Oct 2, 2025
Sep 30, 2025Jeffrey Blizard
director
AGrant or award
Stock Option (right to buy)derivative
+1,342$0.00$01,342Oct 2, 2025
Jun 30, 2025James Tyler
director
AGrant or award
Stock Option (right to buy)derivative
+1,574$0.00$01,574Jul 2, 2025
Jun 30, 2025Gregory Matthew Bazar
director
AGrant or award
Stock Option (right to buy)derivative
+1,574$0.00$01,574Jul 2, 2025
Jun 30, 2025Jeffrey Blizard
director
AGrant or award
Stock Option (right to buy)derivative
+1,574$0.00$01,574Jul 2, 2025
Jun 30, 2025Morgan C. Frank
Chief Executive Officer
AGrant or award
Stock Option (right to buy)derivative
+1,574$0.00$01,574Jul 2, 2025
Jun 30, 2025Ian D. Miller
director
AGrant or award
Stock Option (right to buy)derivative
+1,771$0.00$01,771Jul 2, 2025
Aug 5, 2023Anthony Michael Stolarski
director
CConversion
Common Stock
+103,114$15.00$1.5M148,473Jun 12, 2025
Nov 14, 2023Anthony Michael Stolarski
director
CConversion
Common Stock
+6,900$15.00$104k155,373Jun 12, 2025
Oct 18, 2024Anthony Michael Stolarski
director
AGrant or award
Common Stock
+80,698--236,071Jun 12, 2025
Oct 18, 2024Anthony Michael Stolarski
director
AGrant or award
Common Stock
+76,215--312,286Jun 12, 2025
Oct 18, 2024Anthony Michael Stolarski
director
AGrant or award
Common Stock
+5,400--317,686Jun 12, 2025
Oct 18, 2024Anthony Michael Stolarski
director
AGrant or award
Common Stock
+5,100--322,786Jun 12, 2025
Oct 18, 2024Anthony Michael Stolarski
director
AGrant or award
Common Stock
+11,500--334,286Jun 12, 2025
Oct 18, 2024Anthony Michael Stolarski
director
AGrant or award
Common Stock
+9,000--343,286Jun 12, 2025
Oct 18, 2024Anthony Michael Stolarski
director
AGrant or award
Common Stock
+8,500--351,786Jun 12, 2025
Mar 1, 2019Anthony Michael Stolarski
director
DDisposition to issuer
Class O Warrant (right to buy)derivative
-533$0.00$00Jun 12, 2025
Mar 1, 2019Anthony Michael Stolarski
director
AGrant or award
Class O Warrant (right to buy)derivative
+533$0.00$0533Jun 12, 2025
May 31, 2019Anthony Michael Stolarski
director
DDisposition to issuer
Class O Warrant (right to buy)derivative
-533$0.00$00Jun 12, 2025
May 31, 2019Anthony Michael Stolarski
director
AGrant or award
Class O Warrant (right to buy)derivative
+533$0.00$0533Jun 12, 2025
Aug 5, 2022Anthony Michael Stolarski
director
AGrant or award
Future Advance Convertible Promissory Notederivative
-$1,344,966.00--Jun 12, 2025
Aug 5, 2023Anthony Michael Stolarski
director
CConversion
Future Advance Convertible Promissory Notederivative
-$0.00-0Jun 12, 2025
Aug 5, 2022Anthony Michael Stolarski
director
AGrant or award
Common Stock Purchase Warrant (right to buy)derivative
+89,664--89,664Jun 12, 2025
Oct 18, 2024Anthony Michael Stolarski
director
DDisposition to issuer
Common Stock Purchase Warrant (right to buy)derivative
-89,664--0Jun 12, 2025
Aug 5, 2022Anthony Michael Stolarski
director
AGrant or award
Common Stock Purchase Warrant (right to buy)derivative
+89,664--89,664Jun 12, 2025
Oct 18, 2024Anthony Michael Stolarski
director
DDisposition to issuer
Common Stock Purchase Warrant (right to buy)derivative
-89,664--0Jun 12, 2025
Nov 14, 2022Anthony Michael Stolarski
director
AGrant or award
Future Advance Convertible Promissory Notederivative
-$90,000.00--Jun 12, 2025
Nov 14, 2023Anthony Michael Stolarski
director
CConversion
Future Advance Convertible Promissory Notederivative
-$0.00-0Jun 12, 2025
Nov 14, 2022Anthony Michael Stolarski
director
AGrant or award
Common Stock Purchase Warrant (right to buy)derivative
+6,000--6,000Jun 12, 2025
Oct 18, 2024Anthony Michael Stolarski
director
DDisposition to issuer
Common Stock Purchase Warrant (right to buy)derivative
-6,000--0Jun 12, 2025
Nov 14, 2022Anthony Michael Stolarski
director
AGrant or award
Common Stock Purchase Warrant (right to buy)derivative
+6,000--6,000Jun 12, 2025
Oct 18, 2024Anthony Michael Stolarski
director
DDisposition to issuer
Common Stock Purchase Warrant (right to buy)derivative
-6,000--0Jun 12, 2025
Jul 21, 2023Anthony Michael Stolarski
director
AGrant or award
Asset-Backed Secured Promissory Notederivative
-$100,000.00--Jun 12, 2025
Jan 21, 2024Anthony Michael Stolarski
director
DDisposition to issuer
Asset-Backed Secured Promissory Notederivative
-$0.00--Jun 12, 2025
Jan 21, 2024Anthony Michael Stolarski
director
AGrant or award
Future Advance Convertible Promissory Notederivative
-$149,992.50--Jun 12, 2025
Oct 18, 2024Anthony Michael Stolarski
director
DDisposition to issuer
Future Advance Convertible Promissory Notederivative
-$0.00-0Jun 12, 2025
Jan 21, 2024Anthony Michael Stolarski
director
AGrant or award
Common Stock Purchase Warrant (right to buy)derivative
+9,999--9,999Jun 12, 2025
Oct 18, 2024Anthony Michael Stolarski
director
DDisposition to issuer
Common Stock Purchase Warrant (right to buy)derivative
-9,999--0Jun 12, 2025
Jan 21, 2024Anthony Michael Stolarski
director
AGrant or award
Common Stock Purchase Warrant (right to buy)derivative
+9,999--9,999Jun 12, 2025
Oct 18, 2024Anthony Michael Stolarski
director
DDisposition to issuer
Common Stock Purchase Warrant (right to buy)derivative
-9,999--0Jun 12, 2025
Oct 22, 2024Anthony Michael Stolarski
director
AGrant or award
Stock Option (right to buy)derivative
+41,333$0.00$041,333Jun 12, 2025
Dec 31, 2024Anthony Michael Stolarski
director
AGrant or award
Stock Option (right to buy)derivative
+1,559$0.00$01,559Jun 12, 2025
Apr 3, 2025Anthony Michael Stolarski
director
AGrant or award
Stock Option (right to buy)derivative
+1,761$0.00$01,761Jun 12, 2025
Jun 5, 2025Peter Stegagno
Chief Operating Officer
MOption exercise
Common Stock
+529$22.50$12k2,561Jun 9, 2025
Jun 5, 2025Peter Stegagno
Chief Operating Officer
MOption exercise
Common Stock
+1,333$15.00$20k3,894Jun 9, 2025
Jun 5, 2025Peter Stegagno
Chief Operating Officer
SOpen-market sale
Common Stock
-1,862$27.71$52k2,032Jun 9, 2025
Jun 5, 2025Peter Stegagno
Chief Operating Officer
MOption exercise
Stock Option (right to buy)derivative
-529$0.00$00Jun 9, 2025
Jun 5, 2025Peter Stegagno
Chief Operating Officer
MOption exercise
Stock Option (right to buy)derivative
-1,333$0.00$00Jun 9, 2025
May 27, 2025Gregory Matthew Bazar
director
AGrant or award
Stock Option (right to buy)derivative
+41,333$0.00$041,333May 29, 2025
May 15, 2025Iulian Cioanta
Chief Sci. and Tech. Officer
MOption exercise
Common Stock
+1,777$14.20$25k1,818May 16, 2025
May 15, 2025Iulian Cioanta
Chief Sci. and Tech. Officer
MOption exercise
Common Stock
+529$22.50$12k2,347May 16, 2025
May 15, 2025Iulian Cioanta
Chief Sci. and Tech. Officer
MOption exercise
Common Stock
+1,333$15.00$20k3,680May 16, 2025
May 15, 2025Iulian Cioanta
Chief Sci. and Tech. Officer
SOpen-market sale
Common Stock
-3,639$31.60$115k41May 16, 2025
May 15, 2025Iulian Cioanta
Chief Sci. and Tech. Officer
MOption exercise
Stock Option (right to buy)derivative
-1,777$0.00$08,890May 16, 2025
May 15, 2025Iulian Cioanta
Chief Sci. and Tech. Officer
MOption exercise
Stock Option (right to buy)derivative
-529$0.00$00May 16, 2025
May 15, 2025Iulian Cioanta
Chief Sci. and Tech. Officer
MOption exercise
Stock Option (right to buy)derivative
-1,333$0.00$00May 16, 2025
Apr 29, 2025Opaleye Management Inc.
owner
POpen-market purchase
Common Stock, par value $0.001 per shareindirect: By Opaleye, L.P.
+5,000$25.49$127k965,000Apr 30, 2025
Apr 29, 2025Opaleye Management Inc.
owner
POpen-market purchase
Common Stock, par value $0.001 per shareindirect: By Managed account
+2,998$25.49$76k15,000Apr 30, 2025
Aug 29, 2019Peter Stegagno
Chief Operating Officer
AGrant or award
Common Stock
+885--891Apr 7, 2025
Apr 3, 2025Jeffrey Blizard
director
AGrant or award
Stock Option (right to buy)derivative
+1,761$0.00$01,761Apr 7, 2025
Apr 3, 2025Morgan C. Frank
Chief Executive Officer
AGrant or award
Stock Option (right to buy)derivative
+1,761$0.00$01,761Apr 7, 2025
Apr 3, 2025Ian D. Miller
director
AGrant or award
Stock Option (right to buy)derivative
+1,981$0.00$01,981Apr 7, 2025
Apr 3, 2025James Tyler
director
AGrant or award
Stock Option (right to buy)derivative
+1,761$0.00$01,761Apr 7, 2025
Aug 29, 2019Peter Stegagno
Chief Operating Officer
AGrant or award
Common Stock
+1,141--2,032Apr 7, 2025
Dec 21, 2017Peter Stegagno
Chief Operating Officer
AGrant or award
Class N Warrant (right to buy)derivative
+885$0.00$0885Apr 7, 2025
Jan 23, 2019Peter Stegagno
Chief Operating Officer
DDisposition to issuer
Class N Warrant (right to buy)derivative
-885$0.00$00Apr 7, 2025
Jan 23, 2019Peter Stegagno
Chief Operating Officer
AGrant or award
Class N Warrant (right to buy)derivative
+885$0.00$0885Apr 7, 2025
May 1, 2019Peter Stegagno
Chief Operating Officer
DDisposition to issuer
Class N Warrant (right to buy)derivative
-885$0.00$00Apr 7, 2025
May 1, 2019Peter Stegagno
Chief Operating Officer
AGrant or award
Class N Warrant (right to buy)derivative
+885$0.00$0885Apr 7, 2025
May 31, 2019Peter Stegagno
Chief Operating Officer
DDisposition to issuer
Class N Warrant (right to buy)derivative
-885$0.00$00Apr 7, 2025
May 31, 2019Peter Stegagno
Chief Operating Officer
AGrant or award
Class N Warrant (right to buy)derivative
+885$0.00$0885Apr 7, 2025
Aug 29, 2019Peter Stegagno
Chief Operating Officer
MOption exercise
Class N Warrant (right to buy)derivative
-885$0.00$00Apr 7, 2025
Dec 11, 2017Peter Stegagno
Chief Operating Officer
AGrant or award
Class O Warrant (right to buy)derivative
+1,141$0.00$01,141Apr 7, 2025
Mar 1, 2019Peter Stegagno
Chief Operating Officer
DDisposition to issuer
Class O Warrant (right to buy)derivative
-1,141$0.00$00Apr 7, 2025
Mar 1, 2019Peter Stegagno
Chief Operating Officer
AGrant or award
Class O Warrant (right to buy)derivative
+1,141$0.00$01,141Apr 7, 2025
May 31, 2019Peter Stegagno
Chief Operating Officer
DDisposition to issuer
Class O Warrant (right to buy)derivative
-1,141$0.00$00Apr 7, 2025
May 31, 2019Peter Stegagno
Chief Operating Officer
AGrant or award
Class O Warrant (right to buy)derivative
+1,141$0.00$01,141Apr 7, 2025

Insiders

Everyone who has filed a Form 4 here.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

SNWV insider trading: SANUWAVE Health, Inc. | InsiderTell